The changing face of fungal infections in health care settings

被引：120

作者：

Fridkin, SK ^{[1
]}

机构：

[1] Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Mycot Dis Branch, Div Bacterial & Mycot Dis, Atlanta, GA USA

来源：

CLINICAL INFECTIOUS DISEASES | 2005年 / 41卷 / 10期

关键词：

D O I：

10.1086/497138

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

As strategies to prevent invasive fungal infections among both hospitalized and nonhospitalized patients have evolved, the epidemiology of these infections has changed. Several unique features of select Candida species and molds have facilitated the emergence of these pathogens as more-common causes of infection than in previous years. In this context, the changing pathogen profiles, unique antifungal susceptibilities, and approaches to treatment are outlined.

引用

收藏

页码：1455 / 1460

页数：6

相关论文

共 46 条

[31] Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program [J].

Morgan, J ;

Wannemuehler, KA ;

Marr, KA ;

Hadley, S ;

Kontoyiannis, DP ;

Walsh, TJ ;

Fridkin, SK ;

Pappas, PG ;

Warnock, DW .

MEDICAL MYCOLOGY, 2005, 43 :S49-S58

[32] Multiechinocandin- and multiazole-resistant Candida parapsilosis solates serially obtained during therapy for prosthetic valve endocarditis [J].

Moudgal, V ;

Little, T ;

Boikov, D ;

Vazquez, JA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (02) :767-769

[33] Fusarium infection in hematopoietic stem cell transplant recipients [J].

Nucci, M ;

Marr, KA ;

Queiroz-Telles, F ;

Martins, CA ;

Trabasso, P ;

Costa, S ;

Voltarelli, JC ;

Colombo, AL ;

Imhof, A ;

Pasquini, R ;

Maiolino, A ;

Souza, CA ;

Anaissie, E .

CLINICAL INFECTIOUS DISEASES, 2004, 38 (09) :1237-1242

[34] Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States [J].

Ostrosky-Zeichner, L ;

Rex, JH ;

Pappas, PG ;

Hamill, RJ ;

Larsen, RA ;

Horowitz, HW ;

Powderly, WG ;

Hyslop, N ;

Kauffman, CA ;

Cleary, J ;

Mangino, JE ;

Lee, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (10) :3149-3154

[35] A prospective observational study of candidemia: Epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients [J].

Pappas, PG ;

Rex, JH ;

Lee, J ;

Hamill, RJ ;

Larsen, RA ;

Powderly, W ;

Kauffman, CA ;

Hyslop, N ;

Mangino, JE ;

Chapman, S ;

Horowitz, HW ;

Edwards, JE ;

Dismukes, WE .

CLINICAL INFECTIOUS DISEASES, 2003, 37 (05) :634-643

[36] Guidelines for treatment of candidiasis [J].

Pappas, PG ;

Rex, JH ;

Sobel, JD ;

Filler, SG ;

Dismukes, WE ;

Walsh, TJ ;

Edwards, JE .

CLINICAL INFECTIOUS DISEASES, 2004, 38 (02) :161-189

[37] Rare and emerging opportunistic fungal pathogens:: Concern for resistance beyond Candida albicans and Aspergillus fumigatus [J].

Pfaller, MA ;

Diekema, DJ .

JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (10) :4419-4431

[38] Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents:: A global assessment from the ARTEMIS antifungal surveillance program conducted in 2001 and 2002 [J].

Pfaller, MA ;

Messer, SA ;

Boyken, L ;

Tendolkar, S ;

Hollis, RJ ;

Diekema, DJ .

JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (07) :3142-3146

[39] Twelve years of fluconazole in clinical practice:: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida [J].

Pfaller, MA ;

Diekema, DJ .

CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 :11-23

[40] Development of interpretive breakpoints for antifungal susceptibility testing: Conceptual framework and analysis of in vitro in vivo correlation data for fluconazole, itraconazole, and Candida infections [J].

Rex, JH ;

Pfaller, MA ;

Galgiani, JN ;

Bartlett, MS ;

EspinelIngroff, A ;

Ghannoum, MA ;

Lancaster, M ;

Odds, FC ;

Rinaldi, MG ;

Walsh, TJ ;

Barry, AL .

CLINICAL INFECTIOUS DISEASES, 1997, 24 (02) :235-247

← 1 2 3 4 5 →